To date, a number of less-invasive blood-based biomarkers have been investigated for MM, such osteopontin and fibulin-3, however a poor associated specificity and/or sensitivity have rendered them unsuitable for clinical implementation as diagnostic and/or prognostic biomarkers of MM (51, 52). The gene discussed is EFEMP1; the disease is Miyoshi myopathy.